InvestorsHub Logo

TempePhil

11/11/20 11:15 PM

#282693 RE: Turner2017 #282692

Really. Either Ana is very busy these days and doesn't have time for PRs, or she is laying VERY LOW, or ...??

Jonjones325

11/11/20 11:17 PM

#282695 RE: Turner2017 #282692

True. Wonder why? My guess is they are waiting for something. What? A decision from some agency for something.

Missling has always PRd events. Maybe not in the timeframe we want, but he usually does.

I think many of us have been in biotechs with loudmouth, showboat CEOs that are good at thumping their chest and pandering to the shareholders. Frank Reynolds from NVIV comes to mind.

The FDA or any other regulatory agency, I believe frowns on this type of behavior. I’m sure we can all name several reasons. This kind of quiet we are seeing during a news filled cycle is unusual even for Missling.

This leads me to believe they are in the midst of something. It’s almost if they are purposely not drawing too much attention to themselves. That CTAD non PR took me by surprise. That’s the time you want to be loud.

We will know soon. I don’t believe it’s incompetence.

boi568

11/11/20 11:43 PM

#282697 RE: Turner2017 #282692

No one can accuse Missling of pumping.

TTTav66

11/11/20 11:45 PM

#282698 RE: Turner2017 #282692

A lot of these smaller conferences have historically passed without a PR — frankly I'm surprised to see they even updated the Events page with this one, seeing that a lot of events never even appear there.

An interesting one I found from last week was Nell Rebowe spoke on 11/5 at the ALS ONE Research Symposium, sharing "the company's preclinical data and rationale for Sigma-1 receptors for the treatment of ALS". Unfortunately, I found it after the event was over because I think registration was free and I would have liked to have listened in.
https://2020alsonesymposium.splashthat.com/?fbclid=IwAR1pDDh_qbyYKC2Lwls55ApWo7NcqBvIlO6HpR6R8uO7LQTQTWiPrU0Zn80#g-909773350